Lactic acid derived from tumor metabolic reprogramming upregulates the expression of CD38 through the OXPHOS‐driven Hippo‐TAZ pathway, promoting the conversion of nicotinamide adenine dinucleotide (NAD+) to adenosine and activating adenosine receptors. The gene discussed is CD38; the disease is neoplasm.